1. Home
  2. PKOH vs ALDX Comparison

PKOH vs ALDX Comparison

Compare PKOH & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PKOH
  • ALDX
  • Stock Information
  • Founded
  • PKOH 1907
  • ALDX 2004
  • Country
  • PKOH United States
  • ALDX United States
  • Employees
  • PKOH N/A
  • ALDX N/A
  • Industry
  • PKOH Industrial Specialties
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PKOH Industrials
  • ALDX Health Care
  • Exchange
  • PKOH Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • PKOH 299.9M
  • ALDX 296.0M
  • IPO Year
  • PKOH N/A
  • ALDX 2014
  • Fundamental
  • Price
  • PKOH $18.70
  • ALDX $4.83
  • Analyst Decision
  • PKOH
  • ALDX Strong Buy
  • Analyst Count
  • PKOH 0
  • ALDX 2
  • Target Price
  • PKOH N/A
  • ALDX $9.50
  • AVG Volume (30 Days)
  • PKOH 22.8K
  • ALDX 612.2K
  • Earning Date
  • PKOH 11-05-2025
  • ALDX 11-06-2025
  • Dividend Yield
  • PKOH 2.68%
  • ALDX N/A
  • EPS Growth
  • PKOH 30.26
  • ALDX N/A
  • EPS
  • PKOH 1.68
  • ALDX N/A
  • Revenue
  • PKOH $1,592,500,000.00
  • ALDX N/A
  • Revenue This Year
  • PKOH $0.23
  • ALDX N/A
  • Revenue Next Year
  • PKOH $3.07
  • ALDX $63.48
  • P/E Ratio
  • PKOH $11.10
  • ALDX N/A
  • Revenue Growth
  • PKOH N/A
  • ALDX N/A
  • 52 Week Low
  • PKOH $15.52
  • ALDX $1.14
  • 52 Week High
  • PKOH $34.50
  • ALDX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • PKOH 37.85
  • ALDX 38.48
  • Support Level
  • PKOH $19.62
  • ALDX $4.85
  • Resistance Level
  • PKOH $21.16
  • ALDX $5.27
  • Average True Range (ATR)
  • PKOH 0.80
  • ALDX 0.26
  • MACD
  • PKOH -0.10
  • ALDX -0.04
  • Stochastic Oscillator
  • PKOH 12.68
  • ALDX 15.69

About PKOH Park-Ohio Holdings Corp.

Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: